For the risk of developing influenza, we analyzed the risks among different CYP2C19 metabolizers for the first time, and further observed a significant increase among CYP2C19 normal metabolizers compared to rapid and ultrarapid metabolizers. This evidence concerns the gene CYP2C19 and influenza.